ADM Tronics Accepted for Membership in MTEC - Medical Technology Enterprise Consortium
November 08 2018 - 1:49PM
InvestorsHub NewsWire
ADM Tronics Accepted for
Membership in MTEC - Medical Technology Enterprise
Consortium
Northvale, NJ -- November 08, 2018 -- InvestorsHub
NewsWire -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT)
has been accepted for membership in the Medical Technology
Enterprise Consortium (“MTEC”), a 501(c)3 biomedical technology
consortium collaborating with multiple government agencies to
foster integrated research partnerships to speed availability of
medical technology solutions to the military, veterans and the
civilian population.
ADMT’s expertise in the research, development and
commercialization of therapeutic and diagnostic innovative medical
device technologies aligns with the mission and goals of
MTEC. MTEC membership is comprised of a wide range of
organizations, including large companies, small businesses,
academic research institutions and non-profit organizations.
MTEC facilitates collaboration among its members and government
agencies on biomedical research and development across all areas of
military medicine.
“We are pleased to now be part of MTEC and look forward to
opportunities to apply our medical technology development
capabilities and experience to help optimize the health and
performance of America’s active duty and military veterans,” stated
Andre’ DiMino, President of ADMT.
As previously announced, ADMT is currently in development of
three of its own proprietary therapeutic medical technologies which
could have application in military medicine. These include
the Alvio™ Respiratory Therapy platform; the Aurex-3® tinnitus
treatment modality; and, the Sonotron® musculoskeletal pain therapy
system.
On October 15, 2018 ADMT announced that it has completed
development and engineering to bring the Alvio™ respiratory
technology into production ready status with the initial 100-unit
production run being assembled now. These initial Alvio
production units are slated for user and clinic testing, including
testing at the Mayo Clinic under the direction of Dr. Bruce
Johnson. Dr. Johnson has dedicated his research to improving
treatment of patients with pulmonary conditions. Research
prototypes of the Alvio platform were previously successfully
evaluated in Dr. Johnson’s lab.
In addition to its own technologies, ADMT has developed medical
device technologies for third-party customers which may also have
application in military biomedical research and development.
“The diverse areas of medical technology areas we have been
involved with over many years gives us a broad base of experience
in electronic biomedical technologies which we believe can be very
helpful in potential collaborations developed through our
membership in MTEC,” commented Mr. DiMino.
For more information on MTEC visit mtec-sc.org and view a video
at https://tinyurl.com/y7yubhqv
About ADMT
ADMT is a diversified, technology-based developer and
manufacturer of innovative technologies and products. Its
core competency is its ability to conceptualize a technology, bring
it through development, into manufacturing and commercialization,
all in-house. ADMT has three areas of activity: Medical
Device Design, Engineering, Regulatory and Manufacturing Services;
Proprietary Electronic Medical Devices; and Eco-Friendly,
Water-Based Formulations. The Company’s headquarters,
laboratories, FDA-Registered medical device and manufacturing
operations are in Northvale, NJ. ADMT’s multi-disciplinary
team of engineers, researchers and technologists utilize advanced
technology infrastructure, such as 3-D prototyping, precision
instrumentation and specialized software and peripherals, for
research, development and commercialization of diversified
technologies. Additional information is available at the Company’s
website admtronics.com
Except for historical information contained herein,
the matters set forth in this news release are “forward looking”
statements (as defined in the Private Securities Litigation Reform
Act of 1995), including statements regarding future revenue growth
and performance. Although ADMT believes the expectations
reflected in such forward looking statements are based upon
reasonable assumptions, there can be no assurance that its
expectations will be realized. Forward looking statements involve
risks and uncertainties that could cause actual results to differ
materially from expectations. Factors that could contribute
to such differences include those described from time to time in
ADMT’s SEC filings, news releases and other communications. The
Company assumes no obligation to update information contained in
this news release.
Contact: Andre’ DiMino 201-767-6040 and re@admtronics.com
Adm Tronics Unlimited (QB) (USOTC:ADMT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adm Tronics Unlimited (QB) (USOTC:ADMT)
Historical Stock Chart
From Apr 2023 to Apr 2024